Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Nicole Massoll

Concepts (242)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Thyroid Neoplasms
9
2022
111
1.350
 Why?
Thyroid Nodule
5
2022
31
1.200
 Why?
Carcinoma, Papillary
4
2017
49
0.680
 Why?
Biopsy, Fine-Needle
6
2020
103
0.570
 Why?
Cyclin-Dependent Kinase Inhibitor p16
2
2008
55
0.550
 Why?
Uterus
2
2008
94
0.540
 Why?
Papillomavirus Infections
2
2008
155
0.480
 Why?
Breast Neoplasms
7
2018
1179
0.400
 Why?
Vulvar Neoplasms
3
2008
52
0.370
 Why?
Carcinoma, Squamous Cell
4
2008
318
0.360
 Why?
Cysts
2
2006
51
0.330
 Why?
MicroRNAs
3
2022
355
0.330
 Why?
Uterine Cervical Neoplasms
2
2008
276
0.300
 Why?
Uterine Cervical Dysplasia
1
2008
49
0.300
 Why?
Precancerous Conditions
1
2008
83
0.300
 Why?
Carcinoma, Lobular
1
2007
33
0.280
 Why?
Cytological Techniques
1
2006
14
0.280
 Why?
Carcinoma, Ductal, Breast
1
2007
90
0.270
 Why?
Adenomyoma
1
2005
2
0.260
 Why?
Neoplasms, Hormone-Dependent
1
2005
8
0.260
 Why?
Carcinoma in Situ
2
2008
72
0.260
 Why?
Gynecologic Surgical Procedures
1
2005
30
0.250
 Why?
Focal Adhesion Protein-Tyrosine Kinases
3
2010
20
0.250
 Why?
Biopsy, Needle
1
2006
181
0.250
 Why?
Uterine Neoplasms
1
2005
60
0.250
 Why?
Lymph Nodes
3
2017
263
0.250
 Why?
Carcinoma, Medullary
1
2004
12
0.230
 Why?
Adenocarcinoma, Follicular
1
2002
4
0.220
 Why?
Humans
33
2022
50208
0.210
 Why?
Mastectomy
2
2018
141
0.210
 Why?
Thyrotropin
1
2002
48
0.210
 Why?
Female
21
2020
26635
0.190
 Why?
Focal Adhesion Kinase 1
2
2012
15
0.180
 Why?
Diagnostic Tests, Routine
1
2020
29
0.180
 Why?
Carcinoma, Neuroendocrine
1
2020
24
0.180
 Why?
Diagnosis, Differential
4
2008
1043
0.180
 Why?
Mutation
6
2022
1294
0.180
 Why?
DNA, Neoplasm
2
2018
147
0.170
 Why?
Lung Neoplasms
2
2015
605
0.170
 Why?
Protein Kinase Inhibitors
2
2012
206
0.160
 Why?
Proto-Oncogene Proteins B-raf
2
2017
79
0.160
 Why?
Immunohistochemistry
6
2015
978
0.150
 Why?
Thyroid Gland
3
2020
73
0.150
 Why?
Middle Aged
11
2020
12206
0.140
 Why?
Pancreatic Neoplasms
2
2010
208
0.140
 Why?
Gene Silencing
2
2008
118
0.140
 Why?
Neoplasm Invasiveness
5
2015
266
0.140
 Why?
DNA, Viral
2
2008
134
0.130
 Why?
Sensitivity and Specificity
4
2020
863
0.130
 Why?
Pathology
2
2006
33
0.130
 Why?
PTEN Phosphohydrolase
1
2016
55
0.130
 Why?
Pulmonary Medicine
1
2015
15
0.130
 Why?
Fibroblasts
2
2016
351
0.130
 Why?
Cytodiagnosis
1
2015
42
0.130
 Why?
Aged, 80 and over
6
2020
3154
0.120
 Why?
Adult
10
2020
13324
0.120
 Why?
Cell Proliferation
4
2016
1013
0.120
 Why?
Endosonography
1
2015
93
0.120
 Why?
Granuloma
2
2007
44
0.120
 Why?
Lymphatic Metastasis
3
2017
227
0.120
 Why?
Receptor, erbB-2
2
2018
74
0.110
 Why?
Laryngeal Diseases
1
2013
12
0.110
 Why?
Herpes Simplex
1
2013
21
0.110
 Why?
Laryngectomy
1
2013
28
0.110
 Why?
Purine Nucleosides
1
2012
3
0.110
 Why?
Receptor, IGF Type 1
1
2012
20
0.110
 Why?
Immunoenzyme Techniques
2
2008
145
0.100
 Why?
Cell Movement
2
2009
249
0.090
 Why?
Predictive Value of Tests
2
2020
905
0.090
 Why?
Receptors, Somatomedin
1
2010
8
0.090
 Why?
Vascular Endothelial Growth Factor Receptor-3
1
2009
5
0.090
 Why?
Tissue Fixation
2
2020
37
0.090
 Why?
Aniline Compounds
1
2009
43
0.080
 Why?
Retrospective Studies
5
2022
6134
0.080
 Why?
Aged
6
2020
9405
0.080
 Why?
Promoter Regions, Genetic
2
2008
475
0.080
 Why?
Melanoma
1
2012
290
0.080
 Why?
Fluorescent Antibody Technique, Direct
1
2008
3
0.080
 Why?
Neuroblastoma
1
2008
52
0.080
 Why?
Transglutaminases
1
2008
15
0.080
 Why?
Mastitis
1
2007
3
0.070
 Why?
Biopsy
2
2007
590
0.070
 Why?
Proto-Oncogene Proteins c-met
1
2007
21
0.070
 Why?
Genetic Markers
1
2008
102
0.070
 Why?
GTP-Binding Proteins
1
2008
92
0.070
 Why?
Genes, erbB-2
1
2007
8
0.070
 Why?
Prednisone
1
2007
101
0.070
 Why?
Gene Expression Regulation, Enzymologic
1
2008
180
0.070
 Why?
Group Practice
1
2006
3
0.070
 Why?
Intracellular Signaling Peptides and Proteins
1
2007
143
0.070
 Why?
Cystatins
1
2006
1
0.070
 Why?
Cadherins
1
2007
68
0.070
 Why?
Frozen Sections
1
2006
13
0.070
 Why?
Tumor Suppressor Protein p53
1
2008
203
0.070
 Why?
Specialization
1
2006
46
0.070
 Why?
Colonic Neoplasms
1
2008
159
0.070
 Why?
Genomic Instability
1
2007
93
0.070
 Why?
Polymerase Chain Reaction
2
2005
454
0.070
 Why?
Reverse Transcriptase Polymerase Chain Reaction
4
2008
595
0.070
 Why?
Medicine
1
2006
56
0.070
 Why?
Nuclear Proteins
1
2007
243
0.070
 Why?
Mice
6
2017
5759
0.070
 Why?
RNA, Small Interfering
3
2012
215
0.070
 Why?
Carrier Proteins
1
2007
306
0.070
 Why?
Mullerian Ducts
1
2005
4
0.070
 Why?
Gene Expression
1
2008
609
0.060
 Why?
Antigens, CD
1
2007
221
0.060
 Why?
Fallopian Tubes
1
2005
22
0.060
 Why?
Medical Oncology
1
2006
95
0.060
 Why?
Signal Transduction
1
2012
1622
0.060
 Why?
Data Collection
1
2006
277
0.060
 Why?
Vulva
1
2005
17
0.060
 Why?
ABO Blood-Group System
1
2005
15
0.060
 Why?
Glucocorticoids
1
2007
226
0.060
 Why?
Estrogen Replacement Therapy
1
2005
41
0.060
 Why?
Chromosome Aberrations
1
2007
297
0.060
 Why?
Ovariectomy
1
2005
117
0.060
 Why?
Hysterectomy
1
2005
88
0.060
 Why?
Decision Making
1
2007
267
0.060
 Why?
Mice, Nude
3
2010
254
0.060
 Why?
Carcinoma, Transitional Cell
1
2005
52
0.060
 Why?
Regression Analysis
1
2006
395
0.060
 Why?
Epithelial Cells
1
2006
207
0.060
 Why?
Male
7
2020
25399
0.060
 Why?
Papillomaviridae
1
2005
102
0.060
 Why?
Cell Survival
3
2012
602
0.060
 Why?
Epigenesis, Genetic
1
2008
378
0.060
 Why?
Cohort Studies
2
2020
1422
0.060
 Why?
Cell Line, Tumor
4
2009
1416
0.060
 Why?
Ultrasonography
1
2006
437
0.060
 Why?
Prospective Studies
2
2022
2379
0.060
 Why?
Base Sequence
3
2010
644
0.050
 Why?
Gene Expression Regulation
1
2007
979
0.050
 Why?
Thyroidectomy
1
2002
60
0.050
 Why?
Gene Expression Profiling
1
2007
1037
0.050
 Why?
Adolescent
3
2015
6390
0.050
 Why?
Yersinia pseudotuberculosis
1
2001
4
0.050
 Why?
Yersinia Infections
1
2001
6
0.050
 Why?
Yersinia enterocolitica
1
2001
6
0.050
 Why?
Recombinant Proteins
1
2002
487
0.050
 Why?
Animals
6
2017
13246
0.050
 Why?
Combined Modality Therapy
1
2002
636
0.050
 Why?
Formaldehyde
1
2020
52
0.050
 Why?
Oncogenes
1
2020
57
0.050
 Why?
Appendicitis
1
2001
60
0.040
 Why?
Disease Progression
3
2008
831
0.040
 Why?
Cell Differentiation
1
2002
650
0.040
 Why?
Neoplasm Staging
2
2015
738
0.040
 Why?
Transplantation, Heterologous
2
2010
75
0.040
 Why?
Toxicology
1
1999
29
0.040
 Why?
Antineoplastic Agents
1
2008
1186
0.040
 Why?
Blotting, Western
2
2012
601
0.040
 Why?
DNA Methylation
3
2008
550
0.040
 Why?
DNA Primers
2
2010
207
0.040
 Why?
Young Adult
2
2020
3981
0.040
 Why?
Paraffin Embedding
1
2018
53
0.040
 Why?
Specimen Handling
1
2018
55
0.040
 Why?
Receptors, Progesterone
1
2018
64
0.040
 Why?
Receptors, Estrogen
1
2018
131
0.040
 Why?
Lymphatic System
1
2017
14
0.040
 Why?
Methylene Blue
1
2017
10
0.040
 Why?
Animals, Genetically Modified
1
2017
49
0.040
 Why?
Coloring Agents
1
2017
70
0.040
 Why?
Mice, Inbred Strains
1
2017
161
0.040
 Why?
Prognosis
2
2015
1954
0.040
 Why?
Follow-Up Studies
2
2015
2190
0.030
 Why?
Treatment Outcome
1
2006
5155
0.030
 Why?
Cost Savings
1
2015
60
0.030
 Why?
Apoptosis
2
2012
1112
0.030
 Why?
Mice, Knockout
2
2008
846
0.030
 Why?
Neoplasm Grading
1
2015
123
0.030
 Why?
RNA, Messenger
2
2008
1108
0.030
 Why?
Collagen
1
2016
207
0.030
 Why?
Cost-Benefit Analysis
1
2015
273
0.030
 Why?
Tumor Microenvironment
1
2016
233
0.030
 Why?
Immunoprecipitation
1
2012
59
0.030
 Why?
In Situ Nick-End Labeling
1
2012
57
0.030
 Why?
Flow Cytometry
1
2012
476
0.020
 Why?
Staurosporine
1
2009
12
0.020
 Why?
Cell Line
1
2012
1021
0.020
 Why?
Deoxycytidine
1
2009
28
0.020
 Why?
Drug Synergism
1
2009
151
0.020
 Why?
Cell Adhesion
1
2009
158
0.020
 Why?
Xenograft Model Antitumor Assays
1
2009
212
0.020
 Why?
RNA Interference
1
2009
179
0.020
 Why?
Polymorphism, Single-Stranded Conformational
1
2008
19
0.020
 Why?
Luciferases
1
2008
50
0.020
 Why?
Chromatin Immunoprecipitation
1
2008
49
0.020
 Why?
Adenoviridae
1
2008
51
0.020
 Why?
Florida
1
2008
58
0.020
 Why?
Fluorouracil
1
2008
54
0.020
 Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2008
67
0.020
 Why?
Loss of Heterozygosity
1
2008
77
0.020
 Why?
Histone Deacetylase 2
1
2007
4
0.020
 Why?
Electrophoresis, Polyacrylamide Gel
1
2008
103
0.020
 Why?
Phosphorylation
1
2009
534
0.020
 Why?
Transcriptional Activation
1
2008
121
0.020
 Why?
Co-Repressor Proteins
1
2007
20
0.020
 Why?
Sequence Deletion
1
2007
67
0.020
 Why?
Estrogens
1
2009
228
0.020
 Why?
Drug Screening Assays, Antitumor
1
2008
140
0.020
 Why?
Transfection
1
2008
355
0.020
 Why?
Molecular Chaperones
1
2007
65
0.020
 Why?
Histone Deacetylases
1
2007
51
0.020
 Why?
Ultrasonography, Mammary
1
2007
60
0.020
 Why?
Enzyme Inhibitors
1
2009
386
0.020
 Why?
Kaplan-Meier Estimate
1
2008
465
0.020
 Why?
Tumor Cells, Cultured
1
2007
468
0.020
 Why?
Transcription, Genetic
1
2008
369
0.020
 Why?
Cystatin M
1
2006
20
0.020
 Why?
Chromatin
1
2007
152
0.020
 Why?
5' Untranslated Regions
1
2006
31
0.020
 Why?
Molecular Sequence Data
1
2008
793
0.020
 Why?
RNA, Neoplasm
1
2006
45
0.020
 Why?
Repressor Proteins
1
2007
153
0.020
 Why?
Carcinoma
1
2007
139
0.020
 Why?
Down-Regulation
1
2007
349
0.020
 Why?
Wound Healing
1
2007
205
0.020
 Why?
Cesarean Section
1
2007
187
0.020
 Why?
Protein Binding
1
2007
665
0.020
 Why?
Survival Rate
1
2008
901
0.020
 Why?
Gene Expression Regulation, Neoplastic
1
2009
828
0.020
 Why?
Chi-Square Distribution
1
2005
278
0.010
 Why?
Cells, Cultured
1
2008
1581
0.010
 Why?
Neoplasm Recurrence, Local
1
2008
613
0.010
 Why?
Pregnancy Complications
1
2007
382
0.010
 Why?
Child
2
2008
6851
0.010
 Why?
Tomography, X-Ray Computed
1
2007
1161
0.010
 Why?
Appendix
1
2001
23
0.010
 Why?
Infant, Newborn
1
2008
2766
0.010
 Why?
DNA, Bacterial
1
2001
188
0.010
 Why?
Magnetic Resonance Imaging
1
2007
1541
0.010
 Why?
Environmental Medicine
1
1999
1
0.010
 Why?
Occupational Medicine
1
1999
4
0.010
 Why?
History, Ancient
1
1999
9
0.010
 Why?
Forensic Medicine
1
1999
7
0.010
 Why?
Pregnancy
1
2007
2604
0.010
 Why?
Infant
1
2008
3563
0.010
 Why?
History, 19th Century
1
1999
27
0.010
 Why?
Risk Factors
1
2008
3629
0.010
 Why?
Child, Preschool
1
2008
3883
0.010
 Why?
History, 20th Century
1
1999
99
0.010
 Why?
Massoll's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (242) concept(s)
_
Co-Authors Expand Description
See all (9) people
_
Similar People Expand Description
See all (37) people
_
Same Department Expand Description
Search Department